Angiopoietin Balance in Septic Shock Patients With Acute Lung Injury: Effect of Direct Hemoperfusion With Polymyxin B-Immobilized Fiber

Therapeutic Apheresis and Dialysis

Volumn 15, Issue 4, 2011, Pages 349-354

  Ebihara, Itaru ^a   Hirayama, Kouichi ^b   Nagai, Miho ^b   Kakita, Tomoko ^c   Sakai, Kentaro ^a   Tajima, Reiko ^a   Sato, Chihiro ^a   Kurosawa, Hiromi ^a   Togashi, Amane ^a   Okada, Akiko ^a   Usui, Joichi ^d   Yamagata, Kunihiro ^d   Kobayashi, Masaki ^b  

^a MITO SAISEIKAI GENERAL HOSPITAL   (Japan)

^b Tokyo Medical University Ibaraki Medical Center   (Japan)

^c OSAKA MEDICAL COLLEGE HOSPITAL   (Japan)

^d UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Acute lung injury; Angiopoietin 1; Angiopoietin 2; Direct hemoperfusion with polymyxin B immobilized fiber column; PaO 2 FiO 2 ratio; Sepsis

Indexed keywords

ANGIOPOIETIN; ANGIOPOIETIN 1; ANGIOPOIETIN 2; POLYMYXIN B IMMOBILIZED FIBER; POLYMYXIN DERIVATIVE; TORAYMYXIN; UNCLASSIFIED DRUG;

ACUTE LUNG INJURY; AGED; ARTICLE; BLOOD OXYGEN TENSION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMOPERFUSION; HUMAN; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEPTIC SHOCK; TREATMENT RESPONSE;

ACUTE LUNG INJURY; AGED; AGED, 80 AND OVER; ANGIOPOIETIN-1; ANGIOPOIETIN-2; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMOPERFUSION; HUMANS; MALE; MIDDLE AGED; POLYMYXIN B; SHOCK, SEPTIC;

EID: 80051965073     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2011.00963.x     Document Type: Article

References (20)

1. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003;348:1546-54.
2. Brun-Buisson C, Doyon F, Carlet J. Bacteremia and severe sepsis in adults: a multicenter prospective survey in ICUs and wards of 24 hospitals. French Bacteremia-Sepsis Study Group. Am J Respir Crit Care Med 1996;154:617-24.
3. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000;342:1334-49.
4. Davis S, Aldrich TH, Jones PF etal. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 1996;87:1161-9.
5. Witzenbichler B, Maisonpierre PC, Jones P, Yancopoulos GD, Isner JM. Chemotactic properties of angiopoietin-1 and -2 ligands for the endothelial-specific receptor tyrosine kinase Tie2. J Biol Chem 1998;273:18514-21.
6. Maisonpierre PC, Suri C, Jones PF etal. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997;277:55-60.
7. Asahara T, Chen D, Takahashi T etal. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. Circ Res 1998;83:233-40.
8. Parikh SM, Mammoto T, Schultz A etal. Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLoS Med 2006;3:e46.
9. Mammoto T, Parikh SM, Mammoto A etal. Angiopoietin-1 requires p190 RhoGAP to protect against vascular leakage in vivo. J Biol Chem 2007;282:23910-8.
10. Ong T, McClintock DE, Kallet RH, Ware LB, Matthay MA, Liu KD. Ratio of angiopoietin-2 to angiopoietin-1 as a predictor of mortality in acute lung injury patients. Crit Care Med 2010;38:1845-51.
11. Tani T, Hanasawa K, Endo Y etal. Therapeutic apheresis for septic patients with organ dysfunction: hemoperfusion using a polymyxin B immobilized column. Artif Organs 1998;22:1038-44.
12. Tsushima K, Kubo K, Koizumi T etal. Direct hemoperfusion using a polymyxin B immobilized column improves acute respiratory distress syndrome. J Clin Apher 2002;17:97-102.
13. Tsushima K, Kubo K, Yoshikawa S etal. Effects of PMX-DHP treatment for patients with directly induced acute respiratory distress syndrome. Ther Apher Dial 2007;11:138-45.
14. Bone RC, Balk RA, Cerra FB etal. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992;101:1644-55.
15. Bernard GR, Artigas A, Brigham KL etal. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994;149:818-24.
16. Knaus WA, Zimmerman JE, Wagner DP, Draper EA, Lawrence DE. APACHE-acute physiology and chronic health evaluation: a physiologically based classification system. Crit Care Med 1981;9:591-7.
17. Nakamura T, Fujiwara N, Sato E etal. Effect of polymyxin B-immobilized fiber hemoperfusion on serum high mobility group box-1 protein levels and oxidative stress in patients with acute respiratory distress syndrome. ASAIO J 2009;55:395-9.
18. Sakamoto Y, Mashiko K, Obata T etal. Relationship between treatment resistance to hemoperfusion using a polymyxin B-immobilized fiber column and oxidative stress. ASAIO J 2008;54:412-5.
19. Kushi H, Miki T, Okamaoto K, Nakahara J, Saito T, Tanjoh K. Early hemoperfusion with an immobilized polymyxin B fiber column eliminates humoral mediators and improves pulmonary oxygenation. Crit Care 2005;9:R653-661.
20. Ebihara I, Hirayama K, Nagai K etal. Angiopoietin balance in septic shock patients treated by direct hemoperfusion with polymyxin b-immobilized fiber. Ther Apher Dial 2009;13:520-7.